Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.0170183726795615e-44,38.020339716542246,3809.998283907936,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.273181753270775e-41,0,0,73
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.11993588651179e-29,19.473684210526315,1268.551344137231,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",1.0803064720539877e-26,0,0,55
3,Oxidative phosphorylation WP623,2.413711948060403e-18,21.278350515463917,863.1640740659424,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",3.3952881402716335e-16,0,0,33
4,Nonalcoholic fatty liver disease WP4396,7.498124959122262e-15,5.935132425873166,193.03497948017394,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX', 'PPARA']",7.910521831873987e-13,0,0,47
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.0522476389605535e-09,8.561822965026307,176.99289268182025,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",8.880970072827072e-08,0,0,23
6,Mitochondrial CIV Assembly WP4922,7.962755814815182e-08,9.447714681440443,154.4314522819104,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'SMIM20', 'COX20']",5.6004715897533445e-06,0,0,17
7,Mitochondrial complex III assembly WP4921,0.0003358839588069706,8.826007326007327,70.59698036557918,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.020249004373791655,0,0,8
8,Synaptic Vesicle Pathway WP2267,0.005111469280344924,3.3944954128440368,17.910268832176662,"['UNC13B', 'UNC13C', 'SLC32A1', 'CLTC', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'CPLX3']",0.26963000453819475,0,0,10
9,Proteasome Degradation WP183,0.011298393653472464,2.696408529741863,12.088254837063689,"['PSMB6', 'PSMC5', 'PSMB5', 'UBB', 'H2AFZ', 'PSMC4', 'PSMC1', 'RPN1', 'HLA-B', 'UBA1', 'PSMB10']",0.4189945124968423,0,0,11
10,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.011978718587337914,3.85464318389753,17.05534541180613,"['RPTOR', 'DEPTOR', 'MAP1LC3A', 'WIPI1', 'ATG7', 'COASY', 'FTL']",0.4189945124968423,0,0,7
11,Parkinson's disease pathway WP2371,0.011978718587337914,3.85464318389753,17.05534541180613,"['UBB', 'CASP6', 'CCNE1', 'CYCS', 'UBA1', 'PARK7', 'UBE2J1']",0.4189945124968423,0,0,7
12,Cellular Proteostasis WP4918,0.01290741389208282,8.797445255474452,38.268477009334376,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.4189945124968423,0,0,4
13,Glycolysis in senescence WP5049,0.01290741389208282,8.797445255474452,38.268477009334376,"['LDHA', 'PKM', 'ALDOC', 'GAPDH']",0.4189945124968423,0,0,4
14,Ferroptosis WP4313,0.021007146267197404,2.937118437118437,11.345773078151154,"['MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'SLC3A2', 'SAT2', 'ATG7', 'FTL']",0.580564886630525,0,0,8
15,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.022011938829593364,13.186873290793072,50.32335418564776,"['GSTP1', 'EPHX2', 'COX5A']",0.580564886630525,0,0,3
16,Glutathione metabolism WP100,0.022011938829593364,13.186873290793072,50.32335418564776,"['GPX4', 'IDH1', 'GSS']",0.580564886630525,0,0,3
17,Nanomaterial induced apoptosis WP2507,0.025720585404937175,5.86374695863747,21.46403241418222,"['ENDOG', 'CASP6', 'BAX', 'CYCS']",0.6030048356046381,0,0,4
18,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.025720585404937175,5.86374695863747,21.46403241418222,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.6030048356046381,0,0,4
19,Base Excision Repair WP4752,0.03551679696380547,2.801630208766531,9.351139941941147,"['POLE4', 'PCNA', 'NEIL2', 'MPG', 'TDG', 'APEX1', 'POLD2']",0.7888467536171531,0,0,7
20,Hippo-Yap signaling pathway WP4537,0.043989560445167636,4.396897810218978,13.735042288084243,"['MAP4K2', 'NF2', 'TNIK', 'STK3']",0.9104329144721459,0,0,4
21,Pyrimidine metabolism WP4022,0.0453365624561392,1.9591503267973855,6.060908665207869,"['POLE4', 'POLR3GL', 'POLR1B', 'POLD2', 'NME2', 'ENPP1', 'NME3', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.9104329144721459,0,0,12
22,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.04746332729475642,6.592069279854147,20.09129505996199,"['MAP1LC3A', 'WIPI1', 'ATG7']",0.9104329144721459,0,0,3
23,Amino Acid metabolism WP3925,0.058784698182159256,2.0020850708924103,5.67365621343362,"['LARS2', 'LDHA', 'PKM', 'GOT1', 'MDH2', 'RARS', 'IDH1', 'GSS', 'ODC1', 'SRM']",0.9992968562395984,0,0,10
24,CAMKK2  Pathway WP4874,0.059938961933457394,2.6396709323583183,7.429165196810674,"['RPTOR', 'FIS1', 'MAP1LC3A', 'CAMK4', 'SQSTM1', 'CALM2']",0.9992968562395984,0,0,6
25,Apoptosis Modulation by HSP70 WP384,0.09061259224499207,8.783242258652095,21.089988324176534,"['CASP6', 'CYCS']",0.9992968562395984,0,0,2
26,Cytosine methylation WP3585,0.09061259224499207,8.783242258652095,21.089988324176534,"['IDH1', 'TDG']",0.9992968562395984,0,0,2
27,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.09061259224499207,8.783242258652095,21.089988324176534,"['EPHX2', 'PPARA']",0.9992968562395984,0,0,2
28,Translation Factors WP107,0.09337749766638873,1.9556369556369557,4.637020342937407,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.9992968562395984,0,0,8
29,7q11.23 copy number variation syndrome WP4932,0.09452693229637991,1.6360625574977001,3.859259682161882,"['PCNA', 'CLTC', 'ATP5MC2', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5PO', 'SQSTM1', 'GAPDH', 'VPS28', 'CLASP1']",0.9992968562395984,0,0,13
30,Glycolysis and Gluconeogenesis WP534,0.09728648724600254,2.0528209820067094,4.783268268719382,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'GAPDH']",0.9992968562395984,0,0,7
31,Cori Cycle WP1946,0.12424333278623441,3.2946672743846857,6.871072337810496,"['LDHA', 'PGAM1', 'GAPDH']",0.9992968562395984,0,0,3
32,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.12424333278623441,3.2946672743846857,6.871072337810496,"['GOT1', 'MDH2', 'NAMPT']",0.9992968562395984,0,0,3
33,Urea cycle and metabolism of amino groups WP497,0.12424333278623441,3.2946672743846857,6.871072337810496,"['ODC1', 'CKB', 'SRM']",0.9992968562395984,0,0,3
34,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.1307728143458305,2.510948905109489,5.108007546102941,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.9992968562395984,0,0,4
35,Acetylcholine Synthesis WP528,0.15921328589792572,4.390710382513661,8.067976671471204,"['ACHE', 'CHKA']",0.9992968562395984,0,0,2
36,Dual hijack model of Vif in HIV infection WP3300,0.15921328589792572,4.390710382513661,8.067976671471204,"['UBB', 'ELOB']",0.9992968562395984,0,0,2
37,Histone Modifications WP2369,0.16870776923166328,2.196624087591241,3.9090841906626927,"['SET', 'SETDB1', 'H3F3B', 'SETDB2']",0.9992968562395984,0,0,4
38,Oxidative Damage WP3941,0.16870776923166328,2.196624087591241,3.9090841906626927,"['PCNA', 'BAD', 'TRAF3', 'CYCS']",0.9992968562395984,0,0,4
39,Computational Model of Aerobic Glycolysis WP4629,0.1723956136479774,2.635186873290793,4.6325619804160745,"['LDHA', 'PKM', 'GAPDH']",0.9992968562395984,0,0,3
40,DNA Mismatch Repair WP531,0.1723956136479774,2.635186873290793,4.6325619804160745,"['POLE4', 'PCNA', 'POLD2']",0.9992968562395984,0,0,3
41,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.1723956136479774,2.635186873290793,4.6325619804160745,"['FGF1', 'GTPBP4', 'FGFR2']",0.9992968562395984,0,0,3
42,Melatonin metabolism and effects WP3298,0.1723956136479774,2.635186873290793,4.6325619804160745,"['ACHE', 'APOE', 'CALM2']",0.9992968562395984,0,0,3
43,miRNA regulation of p53 pathway in prostate cancer WP3982,0.1723956136479774,2.635186873290793,4.6325619804160745,"['SESN3', 'SHISA5', 'BAX']",0.9992968562395984,0,0,3
44,Mitochondrial Gene Expression WP391,0.1723956136479774,2.635186873290793,4.6325619804160745,"['CAMK4', 'PPRC1', 'PPARGC1B']",0.9992968562395984,0,0,3
45,Nucleotide metabolism WP404,0.1723956136479774,2.635186873290793,4.6325619804160745,"['NME2', 'OAZ1', 'SRM']",0.9992968562395984,0,0,3
46,Serotonin and anxiety WP3947,0.1723956136479774,2.635186873290793,4.6325619804160745,"['FMR1', 'CRH', 'HTR2C']",0.9992968562395984,0,0,3
47,Zinc homeostasis WP3529,0.1723956136479774,2.635186873290793,4.6325619804160745,"['SLC30A3', 'SLC39A11', 'SLC39A7']",0.9992968562395984,0,0,3
48,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.18571644661948275,inf,inf,['TRAF3'],0.9992968562395984,0,0,1
49,EV release from cardiac cells and their functional effects WP3297,0.18571644661948275,inf,inf,['RGS16'],0.9992968562395984,0,0,1
50,Nanomaterial-induced inflammasome activation WP3890,0.18571644661948275,inf,inf,['CTSB'],0.9992968562395984,0,0,1
51,Nanoparticle triggered regulated necrosis WP2513,0.18571644661948275,inf,inf,['FTL'],0.9992968562395984,0,0,1
52,Valproic acid pathway WP3871,0.18571644661948275,inf,inf,['IVD'],0.9992968562395984,0,0,1
53,Alzheimer's disease WP2059,0.20476610050734145,1.5289058767319637,2.4246718385231283,"['ATP5MD', 'APH1A', 'BAD', 'CHP1', 'CYCS', 'APOE', 'GAPDH', 'CALM2']",0.9992968562395984,0,0,8
54,SARS-CoV-2 mitochondrial interactions WP5038,0.2099093365222947,1.9521492295214924,3.0474602843525402,"['TOMM70', 'NDUFB9', 'IRF3', 'TRAF3']",0.9992968562395984,0,0,4
55,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.21171563859308956,1.647737659963437,2.558131224624383,"['PPP1R14A', 'PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9992968562395984,0,0,6
56,Proximal tubule transport WP4917,0.21171563859308956,1.647737659963437,2.558131224624383,"['ATP6V1A', 'ATP6V1G1', 'SLC13A3', 'SLC47A1', 'SLC3A2', 'ATP6V1F']",0.9992968562395984,0,0,6
57,16p11.2 distal deletion syndrome WP4950,0.22469152669214584,2.1955332725615313,3.277990038021402,"['RAB4A', 'CD81', 'SPNS1']",0.9992968562395984,0,0,3
58,Gastric Cancer Network 2 WP2363,0.22469152669214584,2.1955332725615313,3.277990038021402,"['OTUD5', 'S100A6', 'BRIX1']",0.9992968562395984,0,0,3
59,Hematopoietic Stem Cell Differentiation WP2849,0.22469152669214584,2.1955332725615313,3.277990038021402,"['SEC14L2', 'PIM1', 'ACVR1B']",0.9992968562395984,0,0,3
60,Cytosolic DNA-sensing pathway WP4655,0.23120383812277656,1.6894977168949772,2.4741942937649277,"['CYLD', 'IRF3', 'POLR3GL', 'POLR2K', 'POLR2L']",0.9992968562395984,0,0,5
61,One-carbon metabolism and related pathways WP3940,0.23120383812277656,1.6894977168949772,2.4741942937649277,"['DHFR2', 'GPX4', 'CHKA', 'GSS', 'ETNK1']",0.9992968562395984,0,0,5
62,Kennedy pathway from sphingolipids WP3933,0.23371327032533268,2.9265330904675166,4.254184839895171,"['CHKA', 'ETNK1']",0.9992968562395984,0,0,2
63,Nanoparticle triggered autophagic cell death WP2509,0.23371327032533268,2.9265330904675166,4.254184839895171,"['MAP1LC3A', 'ATG7']",0.9992968562395984,0,0,2
64,Transcription co-factors SKI and SKIL protein partners WP4533,0.23371327032533268,2.9265330904675166,4.254184839895171,"['MERTK', 'STK3']",0.9992968562395984,0,0,2
65,Metabolic reprogramming in colon cancer WP4290,0.2446150101599704,1.550489299924723,2.1831969901619925,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'GAPDH', 'IDH3A']",0.9992968562395984,0,0,6
66,Fragile X Syndrome  WP4549,0.24802518483247718,1.3188419117647059,1.8387623462688032,"['GRIA1', 'RPTOR', 'DEPTOR', 'DUSP3', 'ALDH5A1', 'FMR1', 'CAMK4', 'CLTC', 'AP2S1', 'AKAP5', 'DLGAP3', 'AP2M1']",0.9992968562395984,0,0,12
67,Amyotrophic lateral sclerosis (ALS) WP2447,0.25353838692162756,1.7565693430656935,2.410434785092705,"['GRIA1', 'TOMM40', 'BAD', 'BAX']",0.9992968562395984,0,0,4
68,Differentiation Pathway WP2848,0.25353838692162756,1.7565693430656935,2.410434785092705,"['LEFTY1', 'WNT2B', 'KIT', 'FGF1']",0.9992968562395984,0,0,4
69,NO/cGMP/PKG mediated Neuroprotection WP4008,0.25353838692162756,1.7565693430656935,2.410434785092705,"['BAD', 'PDE3A', 'CYCS', 'CALM2']",0.9992968562395984,0,0,4
70,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.26933049901015466,1.5684931506849316,2.057574462188513,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'PIN1']",0.9992968562395984,0,0,5
71,Regulation of Microtubule Cytoskeleton WP2038,0.26933049901015466,1.5684931506849316,2.057574462188513,"['PARD6A', 'CAMK4', 'STMN1', 'MAPRE1', 'CLASP1']",0.9992968562395984,0,0,5
72,Selenium Micronutrient Network WP15,0.2788582409434503,1.464046313223644,1.8696628672386009,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SELENOH']",0.9992968562395984,0,0,6
73,Autophagy WP4923,0.27945709605453833,1.8814949863263446,2.398730189022762,"['RPTOR', 'DEPTOR', 'ATG7']",0.9992968562395984,0,0,3
74,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.27945709605453833,1.8814949863263446,2.398730189022762,"['H3F3B', 'BCL6', 'H2AFZ']",0.9992968562395984,0,0,3
75,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.27945709605453833,1.8814949863263446,2.398730189022762,"['MAP4K2', 'NF2', 'STK3']",0.9992968562395984,0,0,3
76,PKC-gamma calcium signaling pathway in ataxia WP4760,0.27945709605453833,1.8814949863263446,2.398730189022762,"['PRKCG', 'GRIA1', 'TRPC3']",0.9992968562395984,0,0,3
77,IL-18 signaling pathway WP4754,0.28994844313752716,1.2053882584219462,1.4923335298554703,"['TOMM40', 'USP5', 'PHF20', 'CD81', 'BAD', 'RGS16', 'COX17', 'NDUFC1', 'RND2', 'RPTOR', 'LARS2', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'AARS']",0.9992968562395984,0,0,17
78,DNA Repair Pathways Full Network WP4946,0.29255371073896086,1.2922288181327577,1.5882874894700123,"['POLE4', 'DCLRE1C', 'NEIL2', 'PCNA', 'CENPX', 'MPG', 'TDG', 'APEX1', 'POLD2', 'GTF2H5']",0.9992968562395984,0,0,10
79,Regulatory circuits of the STAT3 signaling pathway WP4538,0.30866734891480385,1.4636225266362253,1.7204752870437054,"['RPTOR', 'DEPTOR', 'TRIM28', 'IFNGR2', 'STMN1']",0.9992968562395984,0,0,5
80,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.30956025742496596,2.1944444444444446,2.5732110701874147,"['ENPP1', 'FGFR2']",0.9992968562395984,0,0,2
81,HIF1A and PPARG regulation of glycolysis WP2456,0.30956025742496596,2.1944444444444446,2.5732110701874147,"['LDHA', 'GAPDH']",0.9992968562395984,0,0,2
82,SARS coronavirus and innate immunity WP4912,0.30956025742496596,2.1944444444444446,2.5732110701874147,"['IRF3', 'TRAF3']",0.9992968562395984,0,0,2
83,Serotonin and anxiety-related events WP3944,0.30956025742496596,2.1944444444444446,2.5732110701874147,"['CRH', 'HTR2C']",0.9992968562395984,0,0,2
84,Wnt signaling in kidney disease WP4150,0.30956025742496596,2.1944444444444446,2.5732110701874147,"['WNT2B', 'DVL3']",0.9992968562395984,0,0,2
85,Apoptosis WP254,0.3140910607304863,1.3867025882805735,1.605901901296071,"['IRF3', 'CASP6', 'TRAF3', 'BAD', 'CYCS', 'BAX']",0.9992968562395984,0,0,6
86,Fas ligand pathway and stress induction of heat shock proteins WP314,0.33521369222900016,1.6459662716499543,1.799019841492021,"['CASP6', 'RIPK2', 'CYCS']",0.9992968562395984,0,0,3
87,White fat cell differentiation WP4149,0.33521369222900016,1.6459662716499543,1.799019841492021,"['IRF3', 'DDIT3', 'NR2F2']",0.9992968562395984,0,0,3
88,15q11.2 copy number variation syndrome WP4940,0.33696784715983075,4.387625113739763,4.772717151357417,['FMR1'],0.9992968562395984,0,0,1
89,15q13.3 copy number variation syndrome WP4942,0.33696784715983075,4.387625113739763,4.772717151357417,['OTUD7A'],0.9992968562395984,0,0,1
90,Composition of Lipid Particles WP3601,0.33696784715983075,4.387625113739763,4.772717151357417,['APOE'],0.9992968562395984,0,0,1
91,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.33696784715983075,4.387625113739763,4.772717151357417,['VIP'],0.9992968562395984,0,0,1
92,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.33696784715983075,4.387625113739763,4.772717151357417,['GSS'],0.9992968562395984,0,0,1
93,Gastric acid production WP2596,0.33696784715983075,4.387625113739763,4.772717151357417,['VIP'],0.9992968562395984,0,0,1
94,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.33696784715983075,4.387625113739763,4.772717151357417,['ELOB'],0.9992968562395984,0,0,1
95,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.33696784715983075,4.387625113739763,4.772717151357417,['BLVRB'],0.9992968562395984,0,0,1
96,Irinotecan pathway WP229,0.33696784715983075,4.387625113739763,4.772717151357417,['CES2'],0.9992968562395984,0,0,1
97,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.33696784715983075,4.387625113739763,4.772717151357417,['BAX'],0.9992968562395984,0,0,1
98,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.33696784715983075,4.387625113739763,4.772717151357417,['APOE'],0.9992968562395984,0,0,1
99,NAD+ metabolism WP3644,0.33696784715983075,4.387625113739763,4.772717151357417,['NAMPT'],0.9992968562395984,0,0,1
100,Peroxiredoxin 2 induced ovarian failure WP4873,0.33696784715983075,4.387625113739763,4.772717151357417,['BAX'],0.9992968562395984,0,0,1
101,"Phase I biotransformations, non P450 WP136",0.33696784715983075,4.387625113739763,4.772717151357417,['CES2'],0.9992968562395984,0,0,1
102,Cysteine and methionine catabolism WP4504,0.3836870067811955,1.7551912568306012,1.6813471052416726,"['GOT1', 'GSS']",0.9992968562395984,0,0,2
103,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3836870067811955,1.7551912568306012,1.6813471052416726,"['BAD', 'BAX']",0.9992968562395984,0,0,2
104,Immune response to tuberculosis WP4197,0.3836870067811955,1.7551912568306012,1.6813471052416726,"['IFNGR2', 'PTPN2']",0.9992968562395984,0,0,2
105,NAD+ biosynthetic pathways WP3645,0.3836870067811955,1.7551912568306012,1.6813471052416726,"['NAPRT', 'NAMPT']",0.9992968562395984,0,0,2
106,Tryptophan catabolism leading to NAD+ production WP4210,0.3836870067811955,1.7551912568306012,1.6813471052416726,"['NAPRT', 'NAMPT']",0.9992968562395984,0,0,2
107,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3836870067811955,1.7551912568306012,1.6813471052416726,"['IRF3', 'TRAF3']",0.9992968562395984,0,0,2
108,Type II diabetes mellitus WP1584,0.3836870067811955,1.7551912568306012,1.6813471052416726,"['SURF1', 'PHKA2']",0.9992968562395984,0,0,2
109,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3890118120462562,1.290894439967768,1.218792267694525,"['BEX3', 'RIPK2', 'RNF7', 'APOE', 'SQSTM1']",0.9992968562395984,0,0,5
110,Ciliary landscape WP4352,0.38935118421629505,1.1142624826008463,1.0510543336591167,"['NDUFA5', 'SSNA1', 'VPS4A', 'COPS7A', 'MYL6B', 'WDR34', 'COX6C', 'LSM4', 'SPATA7', 'MYL6', 'MFAP1', 'PSMC4', 'TNKS1BP1', 'DVL3', 'SNRPB2', 'DCAF11', 'CALM2']",0.9992968562395984,0,0,17
111,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.39071565076297615,1.4627772713460954,1.3746818312024105,"['MDH2', 'IDH3G', 'IDH3A']",0.9992968562395984,0,0,3
112,Energy Metabolism WP1541,0.3909733657103623,1.3503649635036497,1.2681491266086098,"['CAMK4', 'PPRC1', 'PPARA', 'PPARGC1B']",0.9992968562395984,0,0,4
113,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.3909733657103623,1.3503649635036497,1.2681491266086098,"['RPTOR', 'DEPTOR', 'MAP1LC3A', 'IGFBP5']",0.9992968562395984,0,0,4
114,GABA receptor Signaling WP4159,0.3909733657103623,1.3503649635036497,1.2681491266086098,"['GABBR1', 'SLC32A1', 'AP2S1', 'AP2M1']",0.9992968562395984,0,0,4
115,Wnt Signaling Pathway WP363,0.3909733657103623,1.3503649635036497,1.2681491266086098,"['PRKCG', 'DVL3', 'ARRB2', 'ROR2']",0.9992968562395984,0,0,4
116,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4042776468112055,1.0658732565191025,0.9653117307236545,"['YWHAE', 'RPL5', 'SET', 'CLTC', 'ARRB2', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'DNAJB9', 'WASF1', 'CCT7', 'RAB4A', 'HSP90AA1', 'TRPC3', 'RPS6', 'SARS', 'RPL13A', 'PDIA6', 'INPP4B', 'RCN1', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'GAPDH', 'EIF3D', 'PTMA']",0.9992968562395984,0,0,33
117,Ectoderm Differentiation WP2858,0.4203984784711962,1.122856471693681,0.9730138123333936,"['GRAMD1B', 'GREB1', 'ARHGDIG', 'PIM1', 'DMD', 'ROR2', 'NR2F2', 'NF2', 'MZF1', 'CELSR2', 'FGFR2']",0.9992968562395984,0,0,11
118,Apoptosis Modulation and Signaling WP1772,0.4222940032279099,1.1968588997839456,1.0317564244004076,"['ENDOG', 'CASP6', 'TRAF3', 'BAD', 'CYCS', 'BAX']",0.9992968562395984,0,0,6
119,DNA IR-double strand breaks and cellular response via ATM WP3959,0.4291220211785331,1.2189244038559106,1.0312270726288244,"['DCLRE1C', 'PCNA', 'TRIM28', 'BAX', 'STK3']",0.9992968562395984,0,0,5
120,Eukaryotic Transcription Initiation WP405,0.4291220211785331,1.2189244038559106,1.0312270726288244,"['TAF13', 'POLR1B', 'TAF6', 'POLR2I', 'POLR2K']",0.9992968562395984,0,0,5
121,Common Pathways Underlying Drug Addiction WP2636,0.43662178560358095,1.2536496350364963,1.0388843307794668,"['GRIA1', 'PRKCG', 'CAMK4', 'CALM2']",0.9992968562395984,0,0,4
122,Development of ureteric collection system WP5053,0.43662178560358095,1.2536496350364963,1.0388843307794668,"['ROBO2', 'GDF11', 'FAT4', 'FGFR2']",0.9992968562395984,0,0,4
123,Ebola Virus Pathway on Host WP4217,0.44085943029526575,1.1324589389105517,0.9275169461438864,"['IRF3', 'CLTC', 'VPS4A', 'HLA-B', 'DAB2IP', 'MERTK', 'EIF2S1', 'CTSB']",0.9992968562395984,0,0,8
124,DNA Replication WP466,0.4449575239455193,1.3162260711030083,1.065848879440225,"['PCNA', 'POLD2', 'UBA52']",0.9992968562395984,0,0,3
125,Airway smooth muscle cell contraction WP4962,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['PPP1R14A', 'CALM2']",0.9992968562395984,0,0,2
126,Cell migration and invasion through p75NTR WP4561,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['EFNA3', 'CDH11']",0.9992968562395984,0,0,2
127,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['CD63', 'CD81']",0.9992968562395984,0,0,2
128,Hedgehog Signaling Pathway WP4249,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['ARRB2', 'KIF7']",0.9992968562395984,0,0,2
129,MTHFR deficiency WP4288,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['CHKA', 'CYCS']",0.9992968562395984,0,0,2
130,Pregnane X receptor pathway WP2876,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['HSP90AA1', 'PSMC5']",0.9992968562395984,0,0,2
131,Prostaglandin Synthesis and Regulation WP98,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['S100A6', 'PPARGC1B']",0.9992968562395984,0,0,2
132,Type II interferon signaling (IFNG) WP619,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['IFNGR2', 'HLA-B']",0.9992968562395984,0,0,2
133,Urea cycle and associated pathways WP4595,0.4541174414055292,1.4623557984213722,1.1543828379471528,"['GOT1', 'MDH2']",0.9992968562395984,0,0,2
134,MECP2 and Associated Rett Syndrome WP3584,0.45814283882619566,1.1445831015022654,0.8934321169917595,"['GRIA1', 'RBFOX1', 'BCL6', 'SST', 'RPS6', 'MBP']",0.9992968562395984,0,0,6
135,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.4601454033996823,2.1933575978161963,1.702512121984996,['APOE'],0.9992968562395984,0,0,1
136,Autosomal recessive Osteopetrosis pathways WP4788,0.4601454033996823,2.1933575978161963,1.702512121984996,['OSTM1'],0.9992968562395984,0,0,1
137,Caloric restriction and aging WP4191,0.4601454033996823,2.1933575978161963,1.702512121984996,['NAMPT'],0.9992968562395984,0,0,1
138,Cell Differentiation - Index WP2029,0.4601454033996823,2.1933575978161963,1.702512121984996,['LEFTY1'],0.9992968562395984,0,0,1
139,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.4601454033996823,2.1933575978161963,1.702512121984996,['PPARA'],0.9992968562395984,0,0,1
140,Estrogen Receptor Pathway WP2881,0.4601454033996823,2.1933575978161963,1.702512121984996,['PPARA'],0.9992968562395984,0,0,1
141,Hedgehog Signaling Pathway Netpath WP47,0.4601454033996823,2.1933575978161963,1.702512121984996,['KIF7'],0.9992968562395984,0,0,1
142,Homologous recombination WP186,0.4601454033996823,2.1933575978161963,1.702512121984996,['POLD2'],0.9992968562395984,0,0,1
143,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4601454033996823,2.1933575978161963,1.702512121984996,['VEGFB'],0.9992968562395984,0,0,1
144,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.4601454033996823,2.1933575978161963,1.702512121984996,['ECI1'],0.9992968562395984,0,0,1
145,Non-homologous end joining WP438,0.4601454033996823,2.1933575978161963,1.702512121984996,['DCLRE1C'],0.9992968562395984,0,0,1
146,Osteoclast Signaling WP12,0.4601454033996823,2.1933575978161963,1.702512121984996,['ATP6V1G1'],0.9992968562395984,0,0,1
147,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.4601454033996823,2.1933575978161963,1.702512121984996,['FURIN'],0.9992968562395984,0,0,1
148,SARS-CoV-2 and COVID-19 Pathway WP4846,0.4601454033996823,2.1933575978161963,1.702512121984996,['FURIN'],0.9992968562395984,0,0,1
149,mRNA Processing WP411,0.4638232467638958,1.074579831932773,0.8255478181593485,"['LSM7', 'SF3A1', 'CELF1', 'HNRNPA2B1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF7', 'PRPF8', 'SRSF9']",0.9992968562395984,0,0,12
150,Neural Crest Differentiation WP2064,0.46866510510597353,1.1545301610189858,0.8749801100462544,"['LHX2', 'DVL3', 'MBP', 'HDAC8', 'FGFR2']",0.9992968562395984,0,0,5
151,Metapathway biotransformation Phase I and II WP702,0.4713443938389425,1.0968406593406594,0.8250065311226229,"['CYP4Z1', 'CYP4X1', 'GPX4', 'GSTO1', 'EPHX2', 'GSTP1', 'GSS', 'KCNAB3']",0.9992968562395984,0,0,8
152,Pathways in clear cell renal cell carcinoma WP4018,0.4713443938389425,1.0968406593406594,0.8250065311226229,"['RPTOR', 'TOX2', 'LDHA', 'DEPTOR', 'PKM', 'ALDOC', 'GAPDH', 'SQSTM1']",0.9992968562395984,0,0,8
153,Modulators of TCR signaling and T cell activation WP5072,0.4812327756188514,1.1698296836982969,0.8556183263269195,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9992968562395984,0,0,4
154,NRF2 pathway WP2884,0.49058971944479135,1.0670597270047315,0.7599034927199956,"['HSP90AA1', 'FTH1', 'GSTP1', 'SLC39A11', 'BLVRB', 'SLC39A7', 'SQSTM1', 'CES2', 'FTL']",0.9992968562395984,0,0,9
155,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4934199413550516,1.0966636197440585,0.7746773242547004,"['PRKCG', 'BAD', 'RPS6', 'PDGFC', 'BAX', 'FGFR2']",0.9992968562395984,0,0,6
156,Acute viral myocarditis WP4298,0.5073085978083628,1.0965753424657534,0.7441752698588544,"['ENDOG', 'CASP6', 'CYCS', 'BAX', 'DMD']",0.9992968562395984,0,0,5
157,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5073085978083628,1.0965753424657534,0.7441752698588544,"['RPTOR', 'PFKFB2', 'BAD', 'RPS6', 'ZNF516']",0.9992968562395984,0,0,5
158,GDNF/RET signaling axis WP4830,0.5196676663940695,1.2531876138433515,0.8202937214356971,"['ROBO2', 'FAT4']",0.9992968562395984,0,0,2
159,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5196676663940695,1.2531876138433515,0.8202937214356971,"['B4GALT2', 'B3GALT2']",0.9992968562395984,0,0,2
160,Monoamine Transport WP727,0.5196676663940695,1.2531876138433515,0.8202937214356971,"['UNC13B', 'ACHE']",0.9992968562395984,0,0,2
161,Neural Crest Cell Migration during Development WP4564,0.5196676663940695,1.2531876138433515,0.8202937214356971,"['CDH11', 'EPHB3']",0.9992968562395984,0,0,2
162,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.5196676663940695,1.2531876138433515,0.8202937214356971,"['OMG', 'MBP']",0.9992968562395984,0,0,2
163,Toll-like Receptor Signaling related to MyD88 WP3858,0.5196676663940695,1.2531876138433515,0.8202937214356971,"['IRF3', 'TRAF3']",0.9992968562395984,0,0,2
164,Nucleotide Excision Repair WP4753,0.5243741097259406,1.0964872262773722,0.7078372187739669,"['POLE4', 'PCNA', 'POLD2', 'GTF2H5']",0.9992968562395984,0,0,4
165,Regulation of toll-like receptor signaling pathway WP1449,0.5450521879572038,1.0232082952119548,0.6209582358934232,"['OTUD5', 'CYLD', 'CUEDC2', 'IRF3', 'TRAF3', 'SQSTM1', 'RNF41']",0.9992968562395984,0,0,7
166,Complement system WP2806,0.5467616241928662,1.0963992707383774,0.6619426822582516,"['RPS19', 'CD59', 'ARRB2']",0.9992968562395984,0,0,3
167,Copper homeostasis WP3286,0.5467616241928662,1.0963992707383774,0.6619426822582516,"['COX17', 'COMMD1', 'ATOX1']",0.9992968562395984,0,0,3
168,Glycogen Synthesis and Degradation WP500,0.5467616241928662,1.0963992707383774,0.6619426822582516,"['PHKG1', 'PHKA2', 'CALM2']",0.9992968562395984,0,0,3
169,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5467616241928662,1.0963992707383774,0.6619426822582516,"['HSP90AA1', 'CCNE1', 'BAX']",0.9992968562395984,0,0,3
170,ACE Inhibitor Pathway WP554,0.5604560372248042,1.461935092508341,0.8464669599479583,['ATP6AP2'],0.9992968562395984,0,0,1
171,Aspirin and miRNAs WP4707,0.5604560372248042,1.461935092508341,0.8464669599479583,['PPARA'],0.9992968562395984,0,0,1
172,Biogenic Amine Synthesis WP550,0.5604560372248042,1.461935092508341,0.8464669599479583,['ACHE'],0.9992968562395984,0,0,1
173,Biomarkers for urea cycle disorders WP4583,0.5604560372248042,1.461935092508341,0.8464669599479583,['GOT1'],0.9992968562395984,0,0,1
174,Glial Cell Differentiation WP2276,0.5604560372248042,1.461935092508341,0.8464669599479583,['MBP'],0.9992968562395984,0,0,1
175,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.5604560372248042,1.461935092508341,0.8464669599479583,['GABBR1'],0.9992968562395984,0,0,1
176,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.5604560372248042,1.461935092508341,0.8464669599479583,['SQSTM1'],0.9992968562395984,0,0,1
177,Mammalian disorder of sexual development WP4842,0.5604560372248042,1.461935092508341,0.8464669599479583,['FGFR2'],0.9992968562395984,0,0,1
178,TCA cycle in senescence WP5050,0.5604560372248042,1.461935092508341,0.8464669599479583,['GOT1'],0.9992968562395984,0,0,1
179,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5657051138444646,1.0317732932589094,0.5877830207738055,"['BAD', 'STMN1', 'BAX', 'ANGPTL1']",0.9992968562395984,0,0,4
180,Globo Sphingolipid Metabolism WP1424,0.5797202677719496,1.096311475409836,0.5977195286272632,"['ST6GAL1', 'ST6GAL2']",0.9992968562395984,0,0,2
181,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5797202677719496,1.096311475409836,0.5977195286272632,"['IFITM3', 'DDIT3']",0.9992968562395984,0,0,2
182,Imatinib and Chronic Myeloid Leukemia WP3640,0.5797202677719496,1.096311475409836,0.5977195286272632,"['KIT', 'PIM1']",0.9992968562395984,0,0,2
183,Neural Crest Cell Migration in Cancer WP4565,0.5797202677719496,1.096311475409836,0.5977195286272632,"['CDH11', 'EPHB3']",0.9992968562395984,0,0,2
184,Oxidation by Cytochrome P450 WP43,0.5797202677719496,1.096311475409836,0.5977195286272632,"['CYP4Z1', 'CYP4X1']",0.9992968562395984,0,0,2
185,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5797202677719496,1.096311475409836,0.5977195286272632,"['RPTOR', 'BAD']",0.9992968562395984,0,0,2
186,TLR4 Signaling and Tolerance WP3851,0.5797202677719496,1.096311475409836,0.5977195286272632,"['IRF3', 'TRAF3']",0.9992968562395984,0,0,2
187,TP53 network WP1742,0.5797202677719496,1.096311475409836,0.5977195286272632,"['SUMO1', 'BAX']",0.9992968562395984,0,0,2
188,Retinoblastoma gene in cancer WP2446,0.5808252258977552,0.9964715649647157,0.5413883656455559,"['PCNA', 'H2AFZ', 'CCNE1', 'STMN1', 'SAP30']",0.9992968562395984,0,0,5
189,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5933647279183711,1.0118505013673655,0.5281313354891142,"['LDHA', 'PKM', 'BAX']",0.9992968562395984,0,0,3
190,TNF-alpha signaling pathway WP231,0.6152885112148433,0.9529481834425253,0.46281262394594075,"['MAP4K2', 'HSP90AA1', 'BAD', 'BAX', 'KSR2']",0.9992968562395984,0,0,5
191,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6246679333784562,0.9392138939670932,0.4419330819488035,"['PSMC5', 'CCNE1', 'PSMC4', 'PSMC1', 'UBA1', 'UBE2J1']",0.9992968562395984,0,0,6
192,Fatty acid beta-oxidation WP143,0.6340550174160341,0.9742967010726573,0.44390862455909025,"['ECI1', 'CPT1B']",0.9992968562395984,0,0,2
193,Fluoropyrimidine Activity WP1601,0.6340550174160341,0.9742967010726573,0.44390862455909025,"['TDG', 'CES2']",0.9992968562395984,0,0,2
194,Glycosylation and related congenital defects WP4521,0.6340550174160341,0.9742967010726573,0.44390862455909025,"['DPM2', 'MAGT1']",0.9992968562395984,0,0,2
195,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6340550174160341,0.9742967010726573,0.44390862455909025,"['IRF3', 'TRAF3']",0.9992968562395984,0,0,2
196,Methionine De Novo and Salvage Pathway WP3580,0.6340550174160341,0.9742967010726573,0.44390862455909025,"['ODC1', 'SRM']",0.9992968562395984,0,0,2
197,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6340550174160341,0.9742967010726573,0.44390862455909025,"['IDH1', 'IDH3A']",0.9992968562395984,0,0,2
198,Trans-sulfuration and one-carbon metabolism WP2525,0.6340550174160341,0.9742967010726573,0.44390862455909025,"['DHFR2', 'GSS']",0.9992968562395984,0,0,2
199,Photodynamic therapy-induced unfolded protein response WP3613,0.6367342707237255,0.9393801276207839,0.42403888362239595,"['DDIT3', 'DNAJB9', 'PDIA6']",0.9992968562395984,0,0,3
200,Endometrial cancer WP4155,0.6419909185077518,0.9227814060699193,0.4089592979973538,"['BAD', 'BAX', 'FGF1', 'FGFR2']",0.9992968562395984,0,0,4
201,Biomarkers for pyrimidine metabolism disorders WP4584,0.6421416558289674,1.096223839854413,0.48556835075412896,['CKB'],0.9992968562395984,0,0,1
202,"Cerebral organic acidurias, including diseases WP4519",0.6421416558289674,1.096223839854413,0.48556835075412896,['MDH2'],0.9992968562395984,0,0,1
203,Disorders of the Krebs cycle WP4236,0.6421416558289674,1.096223839854413,0.48556835075412896,['DHTKD1'],0.9992968562395984,0,0,1
204,Genes targeted by miRNAs in adipocytes WP1992,0.6421416558289674,1.096223839854413,0.48556835075412896,['TMSB4X'],0.9992968562395984,0,0,1
205,Heart Development WP1591,0.6421416558289674,1.096223839854413,0.48556835075412896,['VEGFB'],0.9992968562395984,0,0,1
206,ID signaling pathway WP53,0.6421416558289674,1.096223839854413,0.48556835075412896,['CCNE1'],0.9992968562395984,0,0,1
207,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6421416558289674,1.096223839854413,0.48556835075412896,['RPS6'],0.9992968562395984,0,0,1
208,Insulin signaling in adipocytes (normal condition) WP3634,0.6421416558289674,1.096223839854413,0.48556835075412896,['RPS6'],0.9992968562395984,0,0,1
209,Iron metabolism in placenta WP2007,0.6421416558289674,1.096223839854413,0.48556835075412896,['FTH1'],0.9992968562395984,0,0,1
210,Matrix Metalloproteinases WP129,0.6421416558289674,1.096223839854413,0.48556835075412896,['MMP16'],0.9992968562395984,0,0,1
211,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6421416558289674,1.096223839854413,0.48556835075412896,['COL5A1'],0.9992968562395984,0,0,1
212,Mitochondrial fatty acid synthesis pathway WP4317,0.6421416558289674,1.096223839854413,0.48556835075412896,['HSD17B12'],0.9992968562395984,0,0,1
213,"NAD metabolism, sirtuins and aging WP3630",0.6421416558289674,1.096223839854413,0.48556835075412896,['NAMPT'],0.9992968562395984,0,0,1
214,Overview of interferons-mediated signaling pathway WP4558,0.6421416558289674,1.096223839854413,0.48556835075412896,['IFNGR2'],0.9992968562395984,0,0,1
215,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.6421416558289674,1.096223839854413,0.48556835075412896,['IRF3'],0.9992968562395984,0,0,1
216,Purinergic signaling WP4900,0.6421416558289674,1.096223839854413,0.48556835075412896,['PANX1'],0.9992968562395984,0,0,1
217,Selective expression of chemokine receptors during T-cell polarization WP4494,0.6421416558289674,1.096223839854413,0.48556835075412896,['IFNGR2'],0.9992968562395984,0,0,1
218,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6421416558289674,1.096223839854413,0.48556835075412896,['IRF3'],0.9992968562395984,0,0,1
219,Trans-sulfuration pathway WP2333,0.6421416558289674,1.096223839854413,0.48556835075412896,['GOT1'],0.9992968562395984,0,0,1
220,Transcriptional cascade regulating adipogenesis WP4211,0.6421416558289674,1.096223839854413,0.48556835075412896,['DDIT3'],0.9992968562395984,0,0,1
221,Kit receptor signaling pathway WP304,0.6767567308062988,0.8765724703737465,0.34225193984955216,"['BAD', 'RPS6', 'KIT']",0.9992968562395984,0,0,3
222,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6767567308062988,0.8765724703737465,0.34225193984955216,"['DLG1', 'CHP1', 'CALM2']",0.9992968562395984,0,0,3
223,Pathways Regulating Hippo Signaling WP4540,0.682371245250712,0.8762340036563071,0.3348803569677195,"['PRKCG', 'KIT', 'CDH11', 'NF2', 'FGFR2', 'STK3']",0.9992968562395984,0,0,6
224,7-oxo-C and 7beta-HC pathways WP5064,0.6827228430690049,0.8766848816029144,0.3346010708407956,"['ACOT7', 'EPHX2']",0.9992968562395984,0,0,2
225,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6827228430690049,0.8766848816029144,0.3346010708407956,"['LDHA', 'RPS6']",0.9992968562395984,0,0,2
226,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6827228430690049,0.8766848816029144,0.3346010708407956,"['RAB4A', 'RABAC1']",0.9992968562395984,0,0,2
227,Netrin-UNC5B signaling pathway WP4747,0.6827228430690049,0.8766848816029144,0.3346010708407956,"['DAPK1', 'PLEKHH1']",0.9992968562395984,0,0,2
228,Notch Signaling WP268,0.6827228430690049,0.8766848816029144,0.3346010708407956,"['APH1A', 'DVL3']",0.9992968562395984,0,0,2
229,Complement and Coagulation Cascades WP558,0.7086578614589081,0.8767970882620564,0.3019535152570582,['CLTC'],0.9992968562395984,0,0,1
230,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7086578614589081,0.8767970882620564,0.3019535152570582,['H3F3B'],0.9992968562395984,0,0,1
231,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7086578614589081,0.8767970882620564,0.3019535152570582,['FGFR2'],0.9992968562395984,0,0,1
232,Overview of nanoparticle effects WP3287,0.7086578614589081,0.8767970882620564,0.3019535152570582,['BAX'],0.9992968562395984,0,0,1
233,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7086578614589081,0.8767970882620564,0.3019535152570582,['LDHA'],0.9992968562395984,0,0,1
234,PPAR-alpha pathway WP2878,0.7086578614589081,0.8767970882620564,0.3019535152570582,['PPARA'],0.9992968562395984,0,0,1
235,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7086578614589081,0.8767970882620564,0.3019535152570582,['ANAPC11'],0.9992968562395984,0,0,1
236,Thiamine metabolic pathways WP4297,0.7086578614589081,0.8767970882620564,0.3019535152570582,['BCKDK'],0.9992968562395984,0,0,1
237,3q29 copy number variation syndrome WP4906,0.7089126757673153,0.8345498783454988,0.2871042905279706,"['GRIA1', 'DLG1', 'NF2', 'WDR34']",0.9992968562395984,0,0,4
238,Adipogenesis WP236,0.7109596982628165,0.8516061807461625,0.29051653561729374,"['BMP3', 'CELF1', 'DDIT3', 'NAMPT', 'MIF', 'PPARA', 'ZMPSTE24']",0.9992968562395984,0,0,7
239,Nephrotic syndrome WP4758,0.7134174337161837,0.8216157702825889,0.27745025361195313,"['COL4A4', 'COQ8B', 'ZMPSTE24']",0.9992968562395984,0,0,3
240,Rett syndrome causing genes WP4312,0.7134174337161837,0.8216157702825889,0.27745025361195313,"['IMPDH2', 'GPS2', 'HDAC8']",0.9992968562395984,0,0,3
241,Allograft Rejection WP2328,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['COL5A1', 'HLA-B']",0.9992968562395984,0,0,2
242,Cardiac Progenitor Differentiation WP2406,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['KIT', 'ROR2']",0.9992968562395984,0,0,2
243,Genes controlling nephrogenesis WP4823,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['ROBO2', 'FGFR2']",0.9992968562395984,0,0,2
244,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['HDAC8', 'NELFE']",0.9992968562395984,0,0,2
245,Nuclear receptors WP170,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['NR2F2', 'PPARA']",0.9992968562395984,0,0,2
246,Oxysterols derived from cholesterol WP4545,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['ACOT7', 'EPHX2']",0.9992968562395984,0,0,2
247,Peptide GPCRs WP24,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['MC1R', 'SSTR2']",0.9992968562395984,0,0,2
248,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['IRF3', 'TRAF3']",0.9992968562395984,0,0,2
249,Splicing factor NOVA regulated synaptic proteins WP4148,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['NTNG1', 'CLASP1']",0.9992968562395984,0,0,2
250,Type 2 papillary renal cell carcinoma WP4241,0.7259528512913712,0.7968206656731247,0.25519792144226344,"['COL21A1', 'ELOB']",0.9992968562395984,0,0,2
251,MAPK Signaling Pathway WP382,0.7303690686924409,0.8619915809428229,0.2708423224667048,"['PRKCG', 'DUSP4', 'MAP4K2', 'DUSP3', 'RASGRF2', 'ARRB2', 'FGF1', 'RASGRP2', 'NGF', 'STK3', 'DDIT3', 'STMN1', 'FGFR2']",0.9992968562395984,0,0,13
252,Hippo-Merlin Signaling Dysregulation WP4541,0.7339680019186894,0.8211265996343693,0.25396611908274186,"['PPP1R14A', 'KIT', 'CDH11', 'NF2', 'FGFR2', 'STK3']",0.9992968562395984,0,0,6
253,Senescence and Autophagy in Cancer WP615,0.7339680019186894,0.8211265996343693,0.25396611908274186,"['GABARAPL1', 'MAP1LC3A', 'PCNA', 'IGFBP5', 'SQSTM1', 'ATG7']",0.9992968562395984,0,0,6
254,16p11.2 proximal deletion syndrome WP4949,0.7351517082649879,0.8110941992220531,0.2495561616256695,"['UNC13B', 'PCNA', 'TMEM219', 'SEZ6L2', 'CCT7']",0.9992968562395984,0,0,5
255,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7354109364732306,0.833943833943834,0.25629248824838885,"['GRIA1', 'DLG1', 'BAD', 'CAMK4', 'RPS6', 'NGF', 'SQSTM1', 'EIF2S1']",0.9992968562395984,0,0,8
256,22q11.2 copy number variation syndrome WP4657,0.7387564381584003,0.796449900464499,0.24115467232006058,"['RANBP1', 'MRPL40', 'DGCR6L', 'FGFR2']",0.9992968562395984,0,0,4
257,Non-small cell lung cancer WP4255,0.7387564381584003,0.796449900464499,0.24115467232006058,"['PRKCG', 'BAD', 'CYCS', 'BAX']",0.9992968562395984,0,0,4
258,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7467779802014529,0.7731245643198027,0.22574259529584323,"['RPTOR', 'RPS6', 'PIM1']",0.9992968562395984,0,0,3
259,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7560539959928212,0.8143794190305819,0.22773508209436943,"['YWHAE', 'SST', 'ATP1A3', 'SSTR2', 'NGF', 'GAPDH', 'SLC25A4', 'PPARGC1B']",0.9992968562395984,0,0,8
260,Alanine and aspartate metabolism WP106,0.7628195956880282,0.7305125872004853,0.1977743876317219,['GOT1'],0.9992968562395984,0,0,1
261,BMP Signaling Pathway in Eyelid Development WP3927,0.7628195956880282,0.7305125872004853,0.1977743876317219,['FGFR2'],0.9992968562395984,0,0,1
262,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7628195956880282,0.7305125872004853,0.1977743876317219,['SST'],0.9992968562395984,0,0,1
263,Cell Differentiation - Index expanded WP2023,0.7628195956880282,0.7305125872004853,0.1977743876317219,['LEFTY1'],0.9992968562395984,0,0,1
264,Ebstein-Barr virus LMP1 signaling WP262,0.7628195956880282,0.7305125872004853,0.1977743876317219,['HSP90AA1'],0.9992968562395984,0,0,1
265,Glycerolipids and Glycerophospholipids WP4722,0.7628195956880282,0.7305125872004853,0.1977743876317219,['ETNK1'],0.9992968562395984,0,0,1
266,Kynurenine Pathway and links to Cellular Senescence WP5044,0.7628195956880282,0.7305125872004853,0.1977743876317219,['EIF2AK1'],0.9992968562395984,0,0,1
267,miRNAs involved in DNA damage response WP1545,0.7628195956880282,0.7305125872004853,0.1977743876317219,['CCNE1'],0.9992968562395984,0,0,1
268,miRNAs involvement in the immune response in sepsis WP4329,0.7628195956880282,0.7305125872004853,0.1977743876317219,['TRAF3'],0.9992968562395984,0,0,1
269,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.7628195956880282,0.7305125872004853,0.1977743876317219,['PPARA'],0.9992968562395984,0,0,1
270,Oxidative Stress WP408,0.7628195956880282,0.7305125872004853,0.1977743876317219,['TXN2'],0.9992968562395984,0,0,1
271,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7628195956880282,0.7305125872004853,0.1977743876317219,['BAX'],0.9992968562395984,0,0,1
272,Signal Transduction of S1P Receptor WP26,0.7628195956880282,0.7305125872004853,0.1977743876317219,['ASAH1'],0.9992968562395984,0,0,1
273,Integrated Cancer Pathway WP1971,0.7640844887862761,0.7302671523983,0.19649802775619102,"['BAD', 'BAX']",0.9992968562395984,0,0,2
274,Monoamine GPCRs WP58,0.7640844887862761,0.7302671523983,0.19649802775619102,"['HTR2C', 'HTR5A']",0.9992968562395984,0,0,2
275,Unfolded protein response WP4925,0.7640844887862761,0.7302671523983,0.19649802775619102,"['DDIT3', 'EIF2S1']",0.9992968562395984,0,0,2
276,Corticotropin-releasing hormone signaling pathway WP2355,0.7662227015390272,0.7616629641383688,0.20281745610908125,"['HSP90AA1', 'TRIM28', 'CRH', 'ARRB2']",0.9992968562395984,0,0,4
277,Head and Neck Squamous Cell Carcinoma WP4674,0.7662227015390272,0.7616629641383688,0.20281745610908125,"['RPTOR', 'TRAF3', 'RPS6', 'FGFR2']",0.9992968562395984,0,0,4
278,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7769567499919864,0.7300212701306594,0.18423590083066682,"['WNT2B', 'DVL3', 'ROR2']",0.9992968562395984,0,0,3
279,Small cell lung cancer WP4658,0.7838215452332838,0.75484175720359,0.18385975477406483,"['TRAF3', 'CCNE1', 'COL4A4', 'CYCS', 'BAX']",0.9992968562395984,0,0,5
280,Ras signaling WP4223,0.7926592272043972,0.7874793767186068,0.18298018513119685,"['PRKCG', 'RASA4', 'BAD', 'RASGRF2', 'KIT', 'KSR2', 'RASGRP2', 'CALM2', 'FGFR2']",0.9992968562395984,0,0,9
281,Aryl Hydrocarbon Receptor Pathway WP2873,0.7975187230438335,0.6739526411657559,0.15248176311161232,"['HSP90AA1', 'BAX']",0.9992968562395984,0,0,2
282,G13 Signaling Pathway WP524,0.7975187230438335,0.6739526411657559,0.15248176311161232,"['ARHGDIG', 'CALM2']",0.9992968562395984,0,0,2
283,Genotoxicity pathway WP4286,0.7975187230438335,0.6739526411657559,0.15248176311161232,"['RPS27', 'PHLDA3']",0.9992968562395984,0,0,2
284,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7975187230438335,0.6739526411657559,0.15248176311161232,"['PRKCG', 'ARRB2']",0.9992968562395984,0,0,2
285,Prader-Willi and Angelman Syndrome WP3998,0.7975187230438335,0.6739526411657559,0.15248176311161232,"['HTR2C', 'NGF']",0.9992968562395984,0,0,2
286,Vitamin D Receptor Pathway WP2877,0.7996984247008448,0.7502742230347349,0.16770173812658587,"['IGFBP5', 'BCL6', 'CCNE1', 'S100A6', 'CLEC16A', 'CLPTM1L']",0.9992968562395984,0,0,6
287,Exercise-induced Circadian Regulation WP410,0.8041124687281341,0.6914551648035312,0.15074838124843068,"['DAZAP2', 'SUMO1', 'GSTP1']",0.9992968562395984,0,0,3
288,Constitutive Androstane Receptor Pathway WP2875,0.8069198280966391,0.6260236578707916,0.13430145708979316,['HSP90AA1'],0.9992968562395984,0,0,1
289,Differentiation of white and brown adipocyte WP2895,0.8069198280966391,0.6260236578707916,0.13430145708979316,['PPARGC1B'],0.9992968562395984,0,0,1
290,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8069198280966391,0.6260236578707916,0.13430145708979316,['RPS6'],0.9992968562395984,0,0,1
291,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8069198280966391,0.6260236578707916,0.13430145708979316,['STK3'],0.9992968562395984,0,0,1
292,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8069198280966391,0.6260236578707916,0.13430145708979316,['BAX'],0.9992968562395984,0,0,1
293,Sleep regulation WP3591,0.8069198280966391,0.6260236578707916,0.13430145708979316,['CRH'],0.9992968562395984,0,0,1
294,Statin inhibition of cholesterol production WP430,0.8069198280966391,0.6260236578707916,0.13430145708979316,['APOE'],0.9992968562395984,0,0,1
295,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8069198280966391,0.6260236578707916,0.13430145708979316,['CALM2'],0.9992968562395984,0,0,1
296,Melanoma WP4685,0.8143145204404415,0.7004379562043795,0.14387597917302825,"['BAD', 'KIT', 'BAX', 'CALM2']",0.9992968562395984,0,0,4
297,Disruption of postsynaptic signaling by CNV WP4875,0.8266835262357992,0.6256830601092896,0.11908834289490577,"['DLG1', 'FMR1']",0.9992968562395984,0,0,2
298,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8284306585537906,0.6567456700091158,0.12361407596077435,"['BAD', 'CYCS', 'BAX']",0.9992968562395984,0,0,3
299,DNA damage response WP707,0.8284306585537906,0.6567456700091158,0.12361407596077435,"['CCNE1', 'CYCS', 'BAX']",0.9992968562395984,0,0,3
300,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8284306585537906,0.6567456700091158,0.12361407596077435,"['PCNA', 'COL4A4', 'TLN1']",0.9992968562395984,0,0,3
301,Wnt signaling WP428,0.835140012576466,0.6733576642335767,0.12130934824842933,"['PRKCG', 'WNT2B', 'DVL3', 'ROR2']",0.9992968562395984,0,0,4
302,Angiogenesis WP1539,0.8428262728929738,0.5476569608735213,0.09364628668127052,['FGFR2'],0.9992968562395984,0,0,1
303,IL-7 signaling pathway WP205,0.8428262728929738,0.5476569608735213,0.09364628668127052,['BAD'],0.9992968562395984,0,0,1
304,Nanoparticle-mediated activation of receptor signaling WP2643,0.8428262728929738,0.5476569608735213,0.09364628668127052,['TLN1'],0.9992968562395984,0,0,1
305,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8428262728929738,0.5476569608735213,0.09364628668127052,['GSTP1'],0.9992968562395984,0,0,1
306,Physiological and pathological hypertrophy of the heart WP1528,0.8428262728929738,0.5476569608735213,0.09364628668127052,['CALM2'],0.9992968562395984,0,0,1
307,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8428262728929738,0.5476569608735213,0.09364628668127052,['HTR2C'],0.9992968562395984,0,0,1
308,Sphingolipid Metabolism (general overview) WP4725,0.8428262728929738,0.5476569608735213,0.09364628668127052,['ASAH1'],0.9992968562395984,0,0,1
309,Sphingolipid Metabolism (integrated pathway) WP4726,0.8428262728929738,0.5476569608735213,0.09364628668127052,['ASAH1'],0.9992968562395984,0,0,1
310,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.8428262728929738,0.5476569608735213,0.09364628668127052,['PPARA'],0.9992968562395984,0,0,1
311,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8428262728929738,0.5476569608735213,0.09364628668127052,['RPS6'],0.9992968562395984,0,0,1
312,Vitamin B12 metabolism WP1533,0.8428262728929738,0.5476569608735213,0.09364628668127052,['APOE'],0.9992968562395984,0,0,1
313,DNA damage response (only ATM dependent) WP710,0.8434343305987637,0.6836472602739726,0.11640682957753935,"['WNT2B', 'BCL6', 'BAD', 'DVL3', 'BAX']",0.9992968562395984,0,0,5
314,miRNA regulation of DNA damage response WP1530,0.8501127023052263,0.6253418413855971,0.1015469774613846,"['CCNE1', 'CYCS', 'BAX']",0.9992968562395984,0,0,3
315,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8501127023052263,0.6253418413855971,0.1015469774613846,"['CCNE1', 'APEX1', 'RPS6']",0.9992968562395984,0,0,3
316,Wnt signaling pathway and pluripotency WP399,0.8501127023052263,0.6253418413855971,0.1015469774613846,"['PRKCG', 'WNT2B', 'DVL3']",0.9992968562395984,0,0,3
317,IL-6 signaling pathway WP364,0.8520100398954153,0.5838494231936855,0.09350755356675075,"['BAD', 'VIP']",0.9992968562395984,0,0,2
318,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8520100398954153,0.5838494231936855,0.09350755356675075,"['CAMK4', 'CALM2']",0.9992968562395984,0,0,2
319,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8520100398954153,0.5838494231936855,0.09350755356675075,"['RPTOR', 'CAMK4']",0.9992968562395984,0,0,2
320,"GPCRs, Class A Rhodopsin-like WP455",0.860020105885504,0.6627923066279231,0.09994875578126627,"['MC1R', 'HTR2C', 'SSTR2', 'HTR5A', 'MCHR1']",0.9992968562395984,0,0,5
321,Integrated breast cancer pathway WP1984,0.8606944179663445,0.695604258504533,0.1043515964943989,"['FER', 'BAD', 'DCAKD', 'ODC1', 'BAX', 'FAU', 'DHTKD1']",0.9992968562395984,0,0,7
322,Spinal Cord Injury WP2431,0.8709507390044396,0.625,0.08635616284697696,"['APEX1', 'OMG', 'MBP', 'MIF']",0.9992968562395984,0,0,4
323,Canonical and non-canonical Notch signaling WP3845,0.872060198389104,0.48670508543120006,0.06662837974174379,['MFAP1'],0.9992968562395984,0,0,1
324,Endothelin Pathways WP2197,0.872060198389104,0.48670508543120006,0.06662837974174379,['CALM2'],0.9992968562395984,0,0,1
325,FOXA2 pathway WP5066,0.872060198389104,0.48670508543120006,0.06662837974174379,['PPARGC1B'],0.9992968562395984,0,0,1
326,miRNA targets in ECM and membrane receptors WP2911,0.872060198389104,0.48670508543120006,0.06662837974174379,['COL5A1'],0.9992968562395984,0,0,1
327,Striated Muscle Contraction Pathway WP383,0.872060198389104,0.48670508543120006,0.06662837974174379,['DMD'],0.9992968562395984,0,0,1
328,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.872060198389104,0.48670508543120006,0.06662837974174379,['PPIB'],0.9992968562395984,0,0,1
329,ATM Signaling Network in Development and Disease  WP3878,0.8739166497500387,0.5472449908925319,0.07375235752805005,"['DCLRE1C', 'TRIM28']",0.9992968562395984,0,0,2
330,Interferon type I signaling pathways WP585,0.8739166497500387,0.5472449908925319,0.07375235752805005,"['RPTOR', 'RPS6']",0.9992968562395984,0,0,2
331,Hepatitis B infection WP4666,0.8739419565424105,0.68000406628037,0.09162464332720321,"['PRKCG', 'PCNA', 'IRF3', 'TRAF3', 'BAD', 'CYCS', 'BAX']",0.9992968562395984,0,0,7
332,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8751580908959223,0.7525822342285079,0.10035739305482458,"['PFKFB2', 'HSP90AA1', 'BAD', 'RPS6', 'VEGFB', 'FGF1', 'NGF', 'RPTOR', 'EFNA3', 'COL5A1', 'PIK3IP1', 'COL4A4', 'PDGFC', 'KIT', 'FGFR2']",0.9992968562395984,0,0,15
333,Osteoblast differentiation WP4787,0.8861967864415714,0.6033224263780519,0.07289115095161586,"['PRKCG', 'WNT2B', 'FGF1', 'FGFR2']",0.9992968562395984,0,0,4
334,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8864033521957513,0.5707264872577384,0.06882001542120995,"['WNT2B', 'DVL3', 'ROR2']",0.9992968562395984,0,0,3
335,Calcium Regulation in the Cardiac Cell WP536,0.8876858482610099,0.6897583096145496,0.0821759930563814,"['PRKCG', 'YWHAE', 'SLC8A3', 'GRK4', 'RGS16', 'CAMK4', 'ATP1B2', 'ARRB2', 'CALM2']",0.9992968562395984,0,0,9
336,EGF/EGFR signaling pathway WP437,0.8927337220577117,0.639675391269452,0.07258200038574386,"['NDUFA13', 'PCNA', 'STMN1', 'AP2S1', 'NEDD8', 'AP2M1']",0.9992968562395984,0,0,6
337,Glucocorticoid Receptor Pathway WP2880,0.8927988568938215,0.5149469623915139,0.058391879229273747,"['HSP90AA1', 'SERPINB9']",0.9992968562395984,0,0,2
338,Notch Signaling Pathway Netpath WP61,0.8927988568938215,0.5149469623915139,0.058391879229273747,"['APH1A', 'SAP30']",0.9992968562395984,0,0,2
339,Phosphodiesterases in neuronal function WP4222,0.8927988568938215,0.5149469623915139,0.058391879229273747,"['GRIA1', 'PDE3A']",0.9992968562395984,0,0,2
340,PPAR signaling pathway WP3942,0.8927988568938215,0.5149469623915139,0.058391879229273747,"['PPARA', 'CPT1B']",0.9992968562395984,0,0,2
341,BDNF-TrkB Signaling WP3676,0.895860642216494,0.43794358507734304,0.04816083619654211,['TRPC3'],0.9992968562395984,0,0,1
342,IL17 signaling pathway WP2112,0.895860642216494,0.43794358507734304,0.04816083619654211,['TRAF3'],0.9992968562395984,0,0,1
343,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.895860642216494,0.43794358507734304,0.04816083619654211,['TRAF3'],0.9992968562395984,0,0,1
344,Tumor suppressor activity of SMARCB1 WP4204,0.895860642216494,0.43794358507734304,0.04816083619654211,['H3F3B'],0.9992968562395984,0,0,1
345,Myometrial relaxation and contraction pathways WP289,0.897751809991996,0.6777236954391732,0.07310038230036915,"['PRKCG', 'YWHAE', 'IGFBP5', 'GRK4', 'GSTO1', 'RGS16', 'CRH', 'ARRB2', 'CALM2']",0.9992968562395984,0,0,9
346,ESC Pluripotency Pathways WP3931,0.8998467818836456,0.5830900243309003,0.061533940705969514,"['WNT2B', 'DVL3', 'FGF1', 'FGFR2']",0.9992968562395984,0,0,4
347,Thermogenesis WP4321,0.8998467818836456,0.5830900243309003,0.061533940705969514,"['RPTOR', 'RPS6', 'ZNF516', 'CPT1B']",0.9992968562395984,0,0,4
348,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9090233456375616,0.48623760372394254,0.046379531862290345,"['GRIA1', 'TMSB4X']",0.9992968562395984,0,0,2
349,Cardiac Hypertrophic Response WP2795,0.9090233456375616,0.48623760372394254,0.046379531862290345,"['CALM2', 'FGFR2']",0.9992968562395984,0,0,2
350,"GPCRs, Other WP117",0.9090233456375616,0.48623760372394254,0.046379531862290345,"['SSTR2', 'CELSR2']",0.9992968562395984,0,0,2
351,MET in type 1 papillary renal cell carcinoma WP4205,0.9090233456375616,0.48623760372394254,0.046379531862290345,"['BAD', 'RPL11']",0.9992968562395984,0,0,2
352,RANKL/RANK signaling pathway WP2018,0.9090233456375616,0.48623760372394254,0.046379531862290345,"['TRAF3', 'SQSTM1']",0.9992968562395984,0,0,2
353,Nuclear Receptors Meta-Pathway WP2882,0.9116020263678202,0.7001487841720899,0.06480000135731734,"['HSP90AA1', 'GSTP1', 'SLC39A11', 'SERPINB9', 'PSMC5', 'FTH1', 'BLVRB', 'BAX', 'SLC39A7', 'PPARA', 'SQSTM1', 'CES2', 'FTL']",0.9992968562395984,0,0,13
354,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9146315507197414,0.5248495897903372,0.04683441339577322,"['EIF2B5', 'CALM2', 'FGFR2']",0.9992968562395984,0,0,3
355,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9152367326920139,0.3980478120605509,0.03525609895555468,['IRF3'],0.9992968562395984,0,0,1
356,Intraflagellar transport proteins binding to dynein WP4532,0.9152367326920139,0.3980478120605509,0.03525609895555468,['WDR34'],0.9992968562395984,0,0,1
357,miRNA regulation of prostate cancer signaling pathways WP3981,0.9152367326920139,0.3980478120605509,0.03525609895555468,['BAD'],0.9992968562395984,0,0,1
358,Pre-implantation embryo WP3527,0.9152367326920139,0.3980478120605509,0.03525609895555468,['DDIT3'],0.9992968562395984,0,0,1
359,Sphingolipid pathway WP1422,0.9152367326920139,0.3980478120605509,0.03525609895555468,['ASAH1'],0.9992968562395984,0,0,1
360,AMP-activated protein kinase (AMPK) signaling WP1403,0.9262065502917306,0.5045578851412944,0.038678404786624376,"['RPTOR', 'CPT1B', 'PPARGC1B']",0.9992968562395984,0,0,3
361,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9262065502917306,0.5045578851412944,0.038678404786624376,"['ENPP1', 'SLC38A2', 'CALM2']",0.9992968562395984,0,0,3
362,Endochondral Ossification WP474,0.9262065502917306,0.5045578851412944,0.038678404786624376,"['ENPP1', 'SLC38A2', 'CALM2']",0.9992968562395984,0,0,3
363,Leptin signaling pathway WP2034,0.9262065502917306,0.5045578851412944,0.038678404786624376,"['BAD', 'RPS6', 'BAX']",0.9992968562395984,0,0,3
364,Bladder cancer WP2828,0.9310103179759289,0.3648013345465575,0.026077793882368833,['DAPK1'],0.9992968562395984,0,0,1
365,IL-2 signaling pathway WP49,0.9310103179759289,0.3648013345465575,0.026077793882368833,['RPS6'],0.9992968562395984,0,0,1
366,MAPK Cascade WP422,0.9310103179759289,0.3648013345465575,0.026077793882368833,['MBP'],0.9992968562395984,0,0,1
367,PI3K-Akt signaling pathway WP4172,0.9316375251967168,0.6747163446795461,0.04777765040320497,"['HSP90AA1', 'BAD', 'RPS6', 'VEGFB', 'FGF1', 'NGF', 'RPTOR', 'EFNA3', 'CCNE1', 'COL4A4', 'PDGFC', 'KIT', 'FGFR2']",0.9992968562395984,0,0,13
368,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9348062456044698,0.43743169398907106,0.029489892947186232,"['PRKCG', 'IFI27L2']",0.9992968562395984,0,0,2
369,Breast cancer pathway WP4262,0.9394292343250802,0.5460045662100457,0.03411588628188867,"['WNT2B', 'KIT', 'DVL3', 'BAX', 'FGF1']",0.9992968562395984,0,0,5
370,Regulation of Actin Cytoskeleton WP51,0.9394292343250802,0.5460045662100457,0.03411588628188867,"['TMSB4X', 'BRK1', 'FGF1', 'WASF1', 'FGFR2']",0.9992968562395984,0,0,5
371,Ethanol effects on histone modifications WP3996,0.9438506966527912,0.33666969972702454,0.01945522811480534,['HDAC8'],0.9992968562395984,0,0,1
372,Folate Metabolism WP176,0.9438506966527912,0.33666969972702454,0.01945522811480534,['GPX4'],0.9992968562395984,0,0,1
373,Interleukin-11 Signaling Pathway WP2332,0.9438506966527912,0.33666969972702454,0.01945522811480534,['RPS6'],0.9992968562395984,0,0,1
374,Lung fibrosis WP3624,0.9438506966527912,0.33666969972702454,0.01945522811480534,['FGF1'],0.9992968562395984,0,0,1
375,Neovascularisation processes WP4331,0.9438506966527912,0.33666969972702454,0.01945522811480534,['KIT'],0.9992968562395984,0,0,1
376,The influence of laminopathies on Wnt signaling WP4844,0.9438506966527912,0.33666969972702454,0.01945522811480534,['ZMPSTE24'],0.9992968562395984,0,0,1
377,Prolactin Signaling Pathway WP2037,0.944937203262471,0.416514875531269,0.023590071897732167,"['RPS6', 'PPIB']",0.9992968562395984,0,0,2
378,DNA IR-damage and cellular response via ATR WP4016,0.9451480916642151,0.46832269826800366,0.02641979419701301,"['PCNA', 'TRIM28', 'BCL6']",0.9992968562395984,0,0,3
379,Glioblastoma signaling pathways WP2261,0.9451480916642151,0.46832269826800366,0.02641979419701301,"['PRKCG', 'CCNE1', 'FGFR2']",0.9992968562395984,0,0,3
380,G1 to S cell cycle control WP45,0.9535575628724212,0.3974995860241762,0.018903285872038548,"['PCNA', 'CCNE1']",0.9992968562395984,0,0,2
381,Toll-like Receptor Signaling Pathway WP75,0.9535575628724212,0.3974995860241762,0.018903285872038548,"['IRF3', 'TRAF3']",0.9992968562395984,0,0,2
382,IL-5 signaling pathway WP127,0.9543029127573395,0.31255686988171066,0.014619578576849583,['RPS6'],0.9992968562395984,0,0,1
383,Vitamin D-sensitive calcium signaling in depression WP4698,0.9543029127573395,0.31255686988171066,0.014619578576849583,['GPX4'],0.9992968562395984,0,0,1
384,Cell cycle WP179,0.9610544165190081,0.47208522391004143,0.018753229909955125,"['YWHAE', 'PCNA', 'CCNE1', 'ANAPC11']",0.9992968562395984,0,0,4
385,Aryl Hydrocarbon Receptor Netpath WP2586,0.9628108063825539,0.2916590840157719,0.01105339782041796,['HSP90AA1'],0.9992968562395984,0,0,1
386,ATM Signaling Pathway WP2516,0.9628108063825539,0.2916590840157719,0.01105339782041796,['CCNE1'],0.9992968562395984,0,0,1
387,IL-3 signaling pathway WP286,0.9628108063825539,0.2916590840157719,0.01105339782041796,['BAD'],0.9992968562395984,0,0,1
388,Pathogenic Escherichia coli infection WP2272,0.9628108063825539,0.2916590840157719,0.01105339782041796,['ARPC3'],0.9992968562395984,0,0,1
389,Target Of Rapamycin (TOR) Signaling WP1471,0.9628108063825539,0.2916590840157719,0.01105339782041796,['RPTOR'],0.9992968562395984,0,0,1
390,Gastrin signaling pathway WP4659,0.9661838263827732,0.4595658855167115,0.01580960250456904,"['BAD', 'RPS6', 'KIT', 'ARRB2']",0.9992968562395984,0,0,4
391,Mesodermal commitment pathway WP2857,0.9661838263827732,0.4595658855167115,0.01580960250456904,"['LEFTY1', 'TRIM28', 'RPL38', 'ACVR2A']",0.9992968562395984,0,0,4
392,ErbB signaling pathway WP673,0.967084622990712,0.3642228293867638,0.012190274587626445,"['PRKCG', 'BAD']",0.9992968562395984,0,0,2
393,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9697357909592613,0.2733735213830755,0.008401212555384093,['BANF1'],0.9992968562395984,0,0,1
394,p53 transcriptional gene network WP4963,0.9697357909592613,0.2733735213830755,0.008401212555384093,['BAX'],0.9992968562395984,0,0,1
395,TGF-beta Receptor Signaling WP560,0.9697357909592613,0.2733735213830755,0.008401212555384093,['LEFTY1'],0.9992968562395984,0,0,1
396,G Protein Signaling Pathways WP35,0.9702477400087898,0.4094405195989061,0.01236667513416077,"['PRKCG', 'AKAP5', 'CALM2']",0.9992968562395984,0,0,3
397,Joubert Syndrome WP4656,0.9723372757305854,0.3495810564663024,0.009806637694348483,"['CEP120', 'DVL3']",0.9992968562395984,0,0,2
398,Circadian rhythm related genes WP3594,0.9743618760820534,0.4936014625228519,0.012820068093857887,"['PRKCG', 'NAMPT', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.9992968562395984,0,0,6
399,p38 MAPK Signaling Pathway WP400,0.9753721500265976,0.2572392014130493,0.00641456520967311,['DDIT3'],0.9992968562395984,0,0,1
400,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9753721500265976,0.2572392014130493,0.00641456520967311,['ZMPSTE24'],0.9992968562395984,0,0,1
401,Androgen receptor signaling pathway WP138,0.9782640326108938,0.385194916617513,0.008464917678466967,"['SUMO1', 'CCNE1', 'PARK7']",0.9992968562395984,0,0,3
402,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9799594964652257,0.24289758366191488,0.004917227988853686,['MBP'],0.9992968562395984,0,0,1
403,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9799594964652257,0.24289758366191488,0.004917227988853686,['LEFTY1'],0.9992968562395984,0,0,1
404,IL-4 signaling pathway WP395,0.9836929215964855,0.23006560988458408,0.0037826242270653744,['BAD'],0.9992968562395984,0,0,1
405,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.984195458136006,0.36364326952294135,0.005793115593653264,"['RPTOR', 'MAP4K2', 'SESN3']",0.9992968562395984,0,0,3
406,TGF-beta Signaling Pathway WP366,0.984195458136006,0.36364326952294135,0.005793115593653264,"['NUP214', 'PARD6A', 'SUMO1']",0.9992968562395984,0,0,3
407,Pancreatic adenocarcinoma pathway WP4263,0.9863361235868392,0.301111739212361,0.004142721305676619,"['BAD', 'BAX']",0.9992968562395984,0,0,2
408,Focal Adhesion WP306,0.9883297117254968,0.4428469618566604,0.005198545316022459,"['PRKCG', 'BAD', 'COL4A4', 'PDGFC', 'VEGFB', 'TLN1']",0.9992968562395984,0,0,6
409,B Cell Receptor Signaling Pathway WP23,0.9885702496418207,0.29101396478445657,0.0033453719809067206,"['BCL6', 'CD81']",0.9992968562395984,0,0,2
410,IL-1 signaling pathway WP195,0.9892038289119826,0.208067940552017,0.002258550992382542,['SQSTM1'],0.9992968562395984,0,0,1
411,Endoderm differentiation WP2853,0.990278932230581,0.33546034639927075,0.0032769865979475525,"['DUSP4', 'TCEAL2', 'NME1']",0.9992968562395984,0,0,3
412,Integrin-mediated Cell Adhesion WP185,0.9904465960656645,0.28156765967448144,0.0027028610049409786,"['GIT2', 'TLN1']",0.9992968562395984,0,0,2
413,AGE/RAGE pathway WP2324,0.9912158980507684,0.19856894697659028,0.0017519558685695352,['CYCS'],0.9992968562395984,0,0,1
414,Oncostatin M Signaling Pathway WP2374,0.9928531686508765,0.18989595284250504,0.0013620272565830688,['RPS6'],0.9992968562395984,0,0,1
415,Insulin Signaling WP481,0.9934041397042163,0.3555787278415016,0.002353116586481416,"['MAP4K2', 'RAB4A', 'ENPP1', 'STX4']",0.9992968562395984,0,0,4
416,Chemokine signaling pathway WP3929,0.9940716820233573,0.3113035551504102,0.0018509985534249998,"['GRK4', 'ARRB2', 'RASGRP2']",0.9992968562395984,0,0,3
417,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9952693899980749,0.174631483166515,0.0008280736355591432,['DMD'],0.9992968562395984,0,0,1
418,Genes related to primary cilium development (based on CRISPR) WP4536,0.9953700669092962,0.24918032786885247,0.0011563672675714697,"['CEP120', 'WDR34']",0.9992968562395984,0,0,2
419,T-cell receptor (TCR) signaling pathway WP69,0.9961513512265093,0.16787989080982713,0.0006473572618261666,['RIPK2'],0.9992968562395984,0,0,1
420,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9981525974974755,0.21780510018214935,0.0004027458186057427,"['WNT2B', 'COL4A4']",0.9992968562395984,0,0,2
421,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9988838715094044,0.1362318016378526,0.00015213711321891075,['PPARGC1B'],0.9992968562395984,0,0,1
422,Ciliopathies WP4803,0.9992968562395984,0.275750202757502,0.00019396023345652456,"['CEP120', 'KIF7', 'WDR34', 'SPATA7']",0.9992968562395984,0,0,4
